Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3061% below fair value
$1.76−0.17 (-8.81%)
Close on Nov 13, 2026Market cap $5.33MP/E –Yield –
Intelligent Bio Solutions r&d expenses
Research and development expenses are spending on new products and technology.
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $341.82K | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $494.67K | – |
See a number that looks wrong?